Cargando…

Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis

Detalles Bibliográficos
Autores principales:	Mazumder, Srestha, McCann, Heather, D’Silva, Susan, Furlong, Sarah, Shepherd, Claire E, Kril, Jillian J, Halliday, Glenda M, Rowe, Dominic B, Kiernan, Matthew C, Tan, Rachel H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976952/ https://www.ncbi.nlm.nih.gov/pubmed/36542498 http://dx.doi.org/10.1093/brain/awac467

Ejemplares similares

Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
por: Tan, Rachel H., et al.
Publicado: (2023)

The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review
por: Mazumder, Srestha, et al.
Publicado: (2022)

Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia
por: Henden, Lyndal, et al.
Publicado: (2023)

Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways
por: Fatima, Manaal, et al.
Publicado: (2015)

Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis
por: Phan, Katherine, et al.
Publicado: (2022)

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
por: Katzeff, Jared S., et al.
Publicado: (2022)

Riluzole and Edavarone: The Hope Against Amyotrophic Lateral Sclerosis
por: Rokade, Aditi V, et al.
Publicado: (2022)

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study
por: Introna, Alessandro, et al.
Publicado: (2018)

Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation
por: Katzeff, Jared S., et al.
Publicado: (2020)

Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
por: Jayaprakash, Kiran, et al.
Publicado: (2020)

Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis
por: Povedano Panades, Mónica, et al.
Publicado: (2021)

Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis
por: Thakore, Nimish J., et al.
Publicado: (2022)

Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes
por: Sala, Gessica, et al.
Publicado: (2019)

Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management
por: Onesti, Emanuela, et al.
Publicado: (2017)

Assessment of Therapeutic Response of Edaravone and Riluzole Combination Therapy in Amyotrophic Lateral Sclerosis Patients
por: Samadhiya, Swapnil, et al.
Publicado: (2022)

Partial Block by Riluzole of Muscle Sodium Channels in Myotubes from Amyotrophic Lateral Sclerosis Patients
por: Deflorio, Cristina, et al.
Publicado: (2014)

Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis
por: Albertini, Claudia, et al.
Publicado: (2022)

Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43
por: Tan, Rachel H, et al.
Publicado: (2013)

Cerebellar Integrity in the Amyotrophic Lateral Sclerosis - Frontotemporal Dementia Continuum
por: Tan, Rachel H., et al.
Publicado: (2014)

A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
por: Dupuis, Luc, et al.
Publicado: (2012)

Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis
por: Dyer, Ann Margaret, et al.
Publicado: (2016)

Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis
por: Fifita, Jennifer A., et al.
Publicado: (2021)

Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
por: Hinchcliffe, Michael, et al.
Publicado: (2017)

From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies
por: Mignani, Serge, et al.
Publicado: (2020)

In silico studies reveal structural deviations of mutant profilin-1 and interaction with riluzole and edaravone in amyotrophic lateral sclerosis
por: Sadr, Ahmad Shahir, et al.
Publicado: (2021)

Functional connectivity–based prediction of global cognition and motor function in riluzole-naive amyotrophic lateral sclerosis patients
por: Wei, Luqing, et al.
Publicado: (2022)

Repeated neurofilament light chain measurements did not capture Riluzole therapeutic effect in amyotrophic lateral sclerosis patients
por: Esselin, Florence, et al.
Publicado: (2022)

Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis
por: Tan, Rachel H., et al.
Publicado: (2017)

Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study
por: Inoue-Shibui, Aya, et al.
Publicado: (2019)

Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia
por: Ahmed, Rebekah M., et al.
Publicado: (2019)

Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum
por: Tse, Nga Yan, et al.
Publicado: (2022)

Spinal cord and brain concentrations of riluzole after oral and intrathecal administration: A potential new treatment route for amyotrophic lateral sclerosis
por: Keifer, Orion P., et al.
Publicado: (2023)

“Huoling Shengji granule” for amyotrophic lateral sclerosis: protocol for a multicenter, randomized, double-blind, riluzole parallel controlled clinical trial
por: Liu, Xiaolu, et al.
Publicado: (2023)

Schizotypal traits across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum: pathomechanistic insights
por: Tse, Nga Yan, et al.
Publicado: (2022)

Functional Biomarkers for Amyotrophic Lateral Sclerosis
por: Huynh, William, et al.
Publicado: (2019)

Riluzole and Prognostic Factors in Amyotrophic Lateral Sclerosis Long-term and Short-term Survival: A Population-Based Study of 1149 Cases in Taiwan
por: Lee, Charles Tzu-Chi, et al.
Publicado: (2013)

Long-Term Use of Riluzole Could Improve the Prognosis of Sporadic Amyotrophic Lateral Sclerosis Patients: A Real-World Cohort Study in China
por: Chen, Lu, et al.
Publicado: (2016)

Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
por: Fang, Ton, et al.
Publicado: (2018)

The Puzzling Case of Hyperexcitability in Amyotrophic Lateral Sclerosis
por: Bae, Jong Seok, et al.
Publicado: (2013)

Regional motor cortex dysfunction in amyotrophic lateral sclerosis
por: Menon, Parvathi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gkt77vcm7glf7pa40pqj691te5